{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:28:21Z","timestamp":1792985301381,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007366","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["2019\/R-Single\/004"],"award-info":[{"award-number":["2019\/R-Single\/004"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007378","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007378","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010395","name":"HHV-6 Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bioorg.2021.105518","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T11:24:21Z","timestamp":1637925861000},"page":"105518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Synthesis and biological evaluation of novel rhodanine-based structures with antiviral activity towards HHV-6 virus"],"prefix":"10.1016","volume":"119","author":[{"given":"Valentina","family":"Gentili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Turrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Schiuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Beltrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Cristofori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Illuminati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Compagnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Trapella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Bortolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fantinati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2021.105518_b0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/095632020601700302","article-title":"Antiviral chemistry and chemotherapy\u2019s current antiviral agents Fact File 2006 (1st edition)","volume":"17","author":"De Clercq","year":"2006","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.bioorg.2021.105518_b0010","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd2485","article-title":"Three decades of antiviral drugs","volume":"6","author":"De Clercq","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Suppl 1","key":"10.1016\/j.bioorg.2021.105518_b0015","doi-asserted-by":"crossref","first-page":"i57","DOI":"10.1093\/jac\/dkm159","article-title":"The priorities for antiviral drug resistance surveillance and research","volume":"60","author":"Pillay","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105518_b0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00232-020-00136-z","article-title":"Entry Inhibitors: Efficient Means to Block Viral Infection","volume":"253","author":"Pattnaik","year":"2020","journal-title":"J. Membr. Biol."},{"issue":"7","key":"10.1016\/j.bioorg.2021.105518_b0025","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrmicro3475","article-title":"Broad-spectrum antivirals against viral fusion","volume":"13","author":"Vigant","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105518_b0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.coviro.2012.12.002","article-title":"HIV-1 entry inhibitors: recent development and clinical use","volume":"3","author":"Henrich","year":"2013","journal-title":"Curr. Opin. Virol."},{"issue":"40","key":"10.1016\/j.bioorg.2021.105518_b0035","doi-asserted-by":"crossref","first-page":"17176","DOI":"10.1073\/pnas.1009445107","article-title":"Polyunsaturated liposomes are antiviral against hepatitis B and C viruses and HIV by decreasing cholesterol levels in infected cells","volume":"107","author":"Pollock","year":"2010","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.bioorg.2021.105518_b0040","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/JVI.02907-13","article-title":"The rigid amphipathic fusion inhibitor dUY11 acts through photosensitization of viruses","volume":"88","author":"Vigant","year":"2014","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105518_b0045","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.bbamem.2014.04.015","article-title":"Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity","volume":"1838","author":"Badani","year":"2014","journal-title":"BBA"},{"issue":"3","key":"10.1016\/j.bioorg.2021.105518_b0050","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CMR.00056-05","article-title":"Peptide antimicrobial agents","volume":"19","author":"Jenssen","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2021.105518_b0055","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1073\/pnas.0712380105","article-title":"A virocidal amphipathic \u03b1-helical peptide that inhibits hepatitis C virus infection in vitro","volume":"105","author":"Cheng","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.bioorg.2021.105518_b0060","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.peptides.2013.07.014","article-title":"A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses","volume":"48","author":"Sample","year":"2013","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105518_b0065","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1080\/21691401.2019.1573824","article-title":"A conceptual review of rhodanine: current applications of antiviral drugs, anticancer and antimicrobial activities","volume":"47","author":"Mousavi","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.bioorg.2021.105518_b0070","first-page":"727","article-title":"Hepatitis C virus entry: an intriguing challenge for drug discovery","volume":"7","author":"Meanwell","year":"2006","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.bioorg.2021.105518_b0075","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/978-1-59745-394-3_22","article-title":"Screening of small-molecule compounds as inhibitors of HCV entry","volume":"510","author":"Yang","year":"2009","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2021.105518_b0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00063198-200405000-00009","article-title":"Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what\u2019s in the pipeline?","volume":"10","author":"Brooks","year":"2004","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.bioorg.2021.105518_b0085","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2174\/092986708784049658","article-title":"Arbidol: a broadspectrum antiviral compound that blocks viral fusion","volume":"15","author":"Boriskin","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2021.105518_b0090","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/JVI.02882-12","article-title":"5-(Perylen-3-yl)ethynyl-arabino-uridine (aUY11), an arabino-based rigid amphipathic fusion inhibitor, targets virion envelope lipids to inhibit fusion of influenza virus, hepatitis C virus, and other enveloped viruses","volume":"87","author":"Colpitts","year":"2013","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105518_b0095","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-3-56","article-title":"Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection","volume":"3","author":"Boriskin","year":"2006","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.bioorg.2021.105518_b0100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1556\/030.65.2018.010","article-title":"Human herpesvirus 6A and 6B and NK cells","volume":"65","author":"Rizzo","year":"2018","journal-title":"Acta Microbiol. Immunol. Hung."},{"issue":"12","key":"10.1016\/j.bioorg.2021.105518_b0105","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.3390\/cells9122608","article-title":"The U94 Gene of Human Herpesvirus 6: A Narrative Review of Its Role and Potential Functions","volume":"9","author":"Caselli","year":"2020","journal-title":"Cells"},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2021.105518_b0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jneuroim.2012.07.004","article-title":"Altered natural killer cells' response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression","volume":"251","author":"Rizzo","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105518_b0115","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3233\/JAD-180777","article-title":"KIR2DS2\/KIR2DL2\/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections","volume":"67","author":"Rizzo","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105518_b0120","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-019-0552-6","article-title":"HHV-6A infection induces amyloid-beta expression and activation of microglial cells","volume":"11","author":"Bortolotti","year":"2019","journal-title":"Alzheimers Res. Ther."},{"issue":"7","key":"10.1016\/j.bioorg.2021.105518_b0125","doi-asserted-by":"crossref","first-page":"e0158304","DOI":"10.1371\/journal.pone.0158304","article-title":"Presence of HHV-6A in Endometrial Epithelial Cells from Women with Primary Unexplained Infertility","volume":"11","author":"Marci","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bioorg.2021.105518_b0130","doi-asserted-by":"crossref","first-page":"e13174","DOI":"10.1111\/aji.13174","article-title":"HHV-6A infection of endometrial epithelial cells affects immune profile and trophoblast invasion","volume":"82","author":"Bortolotti","year":"2019","journal-title":"Am. J. Reprod. Immunol."},{"issue":"7","key":"10.1016\/j.bioorg.2021.105518_b0135","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1128\/AAC.00062-13","article-title":"Selection and recombinant phenotyping of a novel CMX001 and cidofovir resistance mutation in human cytomegalovirus","volume":"57","author":"James","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl 1","key":"10.1016\/j.bioorg.2021.105518_b0140","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/S1386-6532(06)70017-8","article-title":"In search of effective anti-HHV-6 agents","volume":"37","author":"De Clercq","year":"2006","journal-title":"Rev. J. Clin. Virol."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105518_b0145","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/135965350701200608","article-title":"Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet","volume":"12","author":"Bonnafous","year":"2007","journal-title":"Antivir. Ther."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105518_b0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.mcp.2010.01.002","article-title":"PCR with quenching probes enables the rapid detection and identification of ganciclovir-resistance-causing U69 gene mutations in human herpesvirus 6","volume":"24","author":"Isegawa","year":"2010","journal-title":"Mol. Cell. Probes"},{"issue":"11","key":"10.1016\/j.bioorg.2021.105518_b0155","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1248\/bpb.b16-00533","article-title":"Rapid Screening by Cell-Based Fusion Assay for Identifying Novel Antivirals of Glycoprotein B-Mediated Herpes Simplex Virus Type 1 Infection","volume":"39","author":"Maeda","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2021.105518_b0160","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3389\/fmicb.2017.02383","article-title":"Herpes Simplex Virus 1 Envelope Cholesterol Facilitates Membrane Fusion","volume":"8","author":"Wudiri","year":"2017","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105518_b0165","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.virol.2008.05.028","article-title":"Human herpesvirus-6 infection induces the reorganization of membrane microdomains in target cells, which are required for virus entry","volume":"378","author":"Tang","year":"2008","journal-title":"Virology"},{"issue":"12","key":"10.1016\/j.bioorg.2021.105518_b0170","doi-asserted-by":"crossref","first-page":"e0208333","DOI":"10.1371\/journal.pone.0208333","article-title":"Novel broad spectrum virucidal molecules against enveloped viruses","volume":"13","author":"Cagno","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105518_b0175","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1038\/s41598-020-61700-0","article-title":"Ginkgolic acid inhibits fusion of enveloped viruses","volume":"10","author":"Borenstein","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2021.105518_b0180","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.antiviral.2017.11.018","article-title":"Antivirals acting on viral envelopes via biophysical mechanism of actions","volume":"149","author":"Speerstra","year":"2018","journal-title":"Antiviral Res."},{"issue":"5","key":"10.1016\/j.bioorg.2021.105518_b0185","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tetlet.2011.11.095","article-title":"An efficient method for the transformation of 5-ylideneRhodanines into 2,3,5-trisubstituted-4-thiazolidinones","volume":"53","author":"Kaminskyy","year":"2012","journal-title":"Tetrahedron Lett."},{"issue":"23","key":"10.1016\/j.bioorg.2021.105518_b0190","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.1021\/jm900450n","article-title":"Design, Synthesis, and Structure\u2212Activity Relationship of a Novel Series of 2-Aryl 5-(4-Oxo-3-phenethyl-2-thioxothiazolidinylidenemethyl)furans as HIV-1 Entry Inhibitors","volume":"52","author":"Katritzky","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105518_b0195","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1128\/IAI.00803-15","article-title":"Pseudomonas aeruginosa Quorum Sensing Molecule N-(3-Oxododecanoyl)-l-Homoserine-Lactone Induces HLA-G Expression in Human Immune Cells","volume":"83","author":"Bortolotti","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bioorg.2021.105518_b0205","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.3389\/fmicb.2017.02143","article-title":"HHV-6A\/6B infection of NK cells modulates the expression of miRNAs and transcription factors potentially associated to impaired NK activity","volume":"8","author":"Rizzo","year":"2017","journal-title":"Front. Microbiol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821008968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821008968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:21:28Z","timestamp":1758615688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821008968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":40,"alternative-id":["S0045206821008968"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105518","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of novel rhodanine-based structures with antiviral activity towards HHV-6 virus","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105518"}}